{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T17:08:02Z","timestamp":1747674482509,"version":"3.30.1"},"reference-count":14,"publisher":"CAIRN","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,22]]},"abstract":"<jats:p>Introduction\u00a0: Lors de l\u2019\u00e9tude, l\u2019HAS recommandait 3\u00a0options de premier contr\u00f4le (C1) en cas de d\u00e9couverte d\u2019un ASC-US sur un frottis de d\u00e9pistage\u00a0: un frottis \u00e0 6\u00a0mois, un test HPV ou une colposcopie. Notre objectif principal \u00e9tait de conna\u00eetre l\u2019option choisie du C1. Les objectifs secondaires \u00e9taient d\u2019\u00e9valuer le nombre de C1 r\u00e9alis\u00e9s par les m\u00e9decins g\u00e9n\u00e9ralistes, le taux de suivi et celui des comptes-rendus des frottis C1 adapt\u00e9s. M\u00e9thode\u00a0: \u00c9tude r\u00e9trospective descriptive, r\u00e9alis\u00e9e sur les donn\u00e9es de CAP Sant\u00e9\u00a049 (organisme d\u00e9partemental du d\u00e9pistage organis\u00e9 des cancers), concernant les femmes de 25 \u00e0 65\u00a0ans ayant un frottis de d\u00e9pistage avec un r\u00e9sultat ASC-US r\u00e9alis\u00e9 par un m\u00e9decin g\u00e9n\u00e9raliste. R\u00e9sultats\u00a0: 397\u00a0patientes incluses, 373 avec suivi soit 94\u00a0% dont 367\u00a0C1 et 6\u00a0traitements. Parmi les C1\u00a0: 212\u00a0frottis (57,76\u00a0%), 89 tests HPV (24,25\u00a0%), 40\u00a0colposcopies (10,9\u00a0%), 26 techniques coupl\u00e9es\u00a0(7,08\u00a0%). 235 soit 64,03\u00a0% sont r\u00e9alis\u00e9s par les m\u00e9decins g\u00e9n\u00e9ralistes, 130 soit 35,42\u00a0% par les gyn\u00e9cologues et 2 par les sages-femmes soit 0,54\u00a0%. Sur les 126\u00a0comptes-rendus de frottis normaux re\u00e7us par les m\u00e9decins g\u00e9n\u00e9ralistes, 70,63\u00a0% renseignaient l\u2019ant\u00e9c\u00e9dent d\u2019ASC-US. Parmi eux 14 soit 15,7\u00a0% pr\u00e9cisaient un d\u00e9lai de contr\u00f4le conforme aux recommandations. Conclusion\u00a0: Cette \u00e9tude r\u00e9alis\u00e9e en 2014 montre le doublement des tests HPV par rapport \u00e0 l\u2019\u00e9tude similaire de 2011. En d\u00e9cembre 2016, l\u2019INCa a positionn\u00e9 ce test comme r\u00e9f\u00e9rence du contr\u00f4le des ASC-US. En 2018 d\u00e9butera le d\u00e9pistage organis\u00e9 du cancer du col de l\u2019ut\u00e9rus qui impliquera les m\u00e9decins g\u00e9n\u00e9ralistes. Cette \u00e9tude pourra servir de base pour \u00e9valuer les modifications de leur pratique.<\/jats:p>","DOI":"10.3917\/spub.185.0499","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T01:25:51Z","timestamp":1541553951000},"page":"499-505","source":"Crossref","is-referenced-by-count":1,"title":["Analyse du premier contr\u00f4le des frottis ASC-US par les m\u00e9decins g\u00e9n\u00e9ralistes en Maine-et-Loire en 2014"],"prefix":"10.3917","volume":"Vol. 30","author":[{"given":"Laure","family":"Theurier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Tessier Cazeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Le Duc-Banaszuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"de Casabianca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2273","reference":[{"key":"rb1","unstructured":"1Duport N, Jourdan-Da Silva N, Vilena I. Pathologie cervico-ut\u00e9rine\u00a0: d\u00e9pistage et surveillance des l\u00e9sions pr\u00e9canc\u00e9reuses et canc\u00e9reuses. [Internet]. BEH\u00a0; 2014 [cit\u00e9 27\u00a0d\u00e9c 2016]. Disponible sur\u00a0: http:\/\/invs.santepubliquefrance.fr\/beh\/2014\/13-14-15\/pdf\/2014_13-14-15.pdf"},{"key":"rb2","unstructured":"2Rakotomahenina H, Bonneau C, Ramanah R, Rouzier R, Brun J, Riethmuller D. Epid\u00e9miologie, pr\u00e9vention et d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus. EMC - Gyn\u00e9cologie\u00a0; 2016."},{"key":"rb3","unstructured":"3Institut de veille sanitaire r\u00e9dig\u00e9 par Nicolas Duport. Donn\u00e9es \u00e9pid\u00e9miologiques sur le cancer du col de l\u2019ut\u00e9rus\u00a0: \u00e9tat des connaissances. [Internet]. 2007 [cit\u00e9 15\u00a0nov 2015]. Disponible sur\u00a0: http:\/\/www.sante.gouv.fr\/IMG\/pdf\/cancer_col_uterus__connaissances.pdf"},{"key":"rb4","unstructured":"4HAS. \u00c9tat des lieux et recommandations pour le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus en France \u2013 Argumentaire [Internet]. 2010 [cit\u00e9 8\u00a0mars 2017]. Disponible sur\u00a0: http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2010-11\/argumentaire_recommandations_depistage_cancer_du_col_de_luterus.pdf"},{"key":"rb5","unstructured":"5Duport N, Beltzer N. D\u00e9pistage organis\u00e9 du cancer du col de l\u2019ut\u00e9rus. \u00c9valuation du d\u00e9pistage organis\u00e9 du cancer du col de l\u2019ut\u00e9rus dans les quatre d\u00e9partements p\u00e9rennes et les neuf d\u00e9partements exp\u00e9rimentaux. Exp\u00e9rimentation 2010-2014. [Internet]. Sant\u00e9 publique France\u00a0; 2016. Disponible sur\u00a0: http:\/\/www.santepubliquefrance.fr"},{"key":"rb6","doi-asserted-by":"crossref","unstructured":"6Giuria C, Guiheneuc E, Coimet F, Caillez E, Baron C. Suivi par les m\u00e9decins g\u00e9n\u00e9ralistes des frottis cervico-ut\u00e9rins class\u00e9s ASC-US. Sant\u00e9 Publique. 31 d\u00e9c 2015;27(5):659-67.","DOI":"10.3917\/spub.155.0659"},{"key":"rb7","doi-asserted-by":"crossref","unstructured":"7Siebers AG, Klinkhamer PJJM, Grefte JMM, Massuger LFAG, Vedder\u00a0JEM, Beijers-Broos A, et al. Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors\u00a0: A Randomized Controlled Trial. JAMA. 28\u00a0oct 2009;302(16):1757-64.","DOI":"10.1001\/jama.2009.1569"},{"key":"rb8","doi-asserted-by":"crossref","unstructured":"8Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd\u00a0; 2013 [cit\u00e9 4\u00a0mai 2017]. Disponible sur\u00a0: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD008054.pub2\/abstract","DOI":"10.1002\/14651858.CD008054.pub2"},{"key":"rb9","unstructured":"9Conduite \u00e0 tenir devant une femme ayant une cytologie cervico ut\u00e9rine anormale. Collection recommandations et r\u00e9f\u00e9rentiels, version interactive, INCa, d\u00e9cembre 2016."},{"key":"rb10","doi-asserted-by":"crossref","unstructured":"10Ducancelle A, Reiser J, Pivert A, Le Guillou-Guillemette H, Le\u00a0Duc-Banaszuk AS, Lunel-Fabiani F. Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics. J Infect. sept 2015;71(3):377-84.","DOI":"10.1016\/j.jinf.2015.05.001"},{"key":"rb11","doi-asserted-by":"crossref","unstructured":"11Boulanger J-C, Sevestre H. ASCUS\u00a0: \u00e9tat des lieux. Gyn\u00e9cologie Obst\u00e9trique Fertil. janv 2006;34(1):44-8.","DOI":"10.1016\/j.gyobfe.2005.11.003"},{"key":"rb12","unstructured":"12HAS. \u00c9tat des lieux et recommandations pour le d\u00e9pistage du cancer du col de l\u2019ut\u00e9rus en France. Recommandation en sant\u00e9 publique. 2010."},{"key":"rb13","doi-asserted-by":"crossref","unstructured":"13Solomon D, Davey D, Kurman R, Moriarty A, O\u2019Connor D, Prey M, et\u00a0al. The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology. JAMA. 24 avr 2002;287(16):2114-9.","DOI":"10.1001\/jama.287.16.2114"},{"key":"rb14","doi-asserted-by":"crossref","unstructured":"14Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytol. 19\u00a0mai 2015;59(2):121-32.","DOI":"10.1159\/000381842"}],"container-title":["Sant\u00e9 Publique"],"original-title":[],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T05:14:43Z","timestamp":1702012483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cairn.info\/revue-sante-publique-2018-4-page-499.htm?ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10,22]]}},"URL":"https:\/\/doi.org\/10.3917\/spub.185.0499","relation":{},"ISSN":["0995-3914"],"issn-type":[{"type":"print","value":"0995-3914"}],"subject":[],"published":{"date-parts":[[2018,10,22]]}}}